On September 15, 2021, all staff gathered at the Kempinski Hotel in Shanghai to commemorate ConFlow MedTech's first anniversary.
The management team sincerely thanks ConFlow MedTech partners for their pioneering efforts in the past year. The company's four research projects have yielded impressive results. The FreeFlow percutaneous atrial septal shunt system has successfully completed animal testing and type tests, and clinical trials are set to begin soon. Let's anticipate the arrival of this historic moment for ConFlow MedTech.
Ms. Chen Xiumin, General Manager, delivered a speech
Ms. Chen Xiumin, General Manager of ConFlow MedTech, jokingly refers to the founding team as "One King Kong and Eighteen Arhats (As the old saying goes, each Arhat has their own representative attributes)" They have come to ConFlow MedTech, in pursuit of their ideals, to create excellence and showcase their unique talents.
Ambition:
ConFlow MedTech aims to leverage the innovative development platform to rapidly enhance their personal abilities. We aspire to reap significant rewards through hard work and contribute more to our families.
My ambition aligns with ConFlow MedTech's vision and mission:
Vision:
To become a top-tier manufacturer of innovative cardiovascular products with international influence.
Mission:
To enable Chinese patients to access cutting-edge international technology and treatments through continuous independent research and the clinical application of advanced technologies.
Speeches and speeches by department managers and representatives
Department managers and representatives will deliver comprehensive summaries and discussions about the work in 2021. They will then create practical plans and development directions for the second half of the year, based on the tasks at hand.
Blessings and messages
The meeting concluded with employees extending well-wishes for the company's first anniversary. Ms. Chen Xiumin delivered an anniversary message and cut the celebratory cake, symbolizing the company's fresh start. The gathering ended on a high note with everyone sharing blessings and laughter.
The first anniversary of ConFlow MedTech has successfully concluded. We hope that ConFlow MedTech continues to shine in the industry and achieve greater success!
ConFlow MedTech
ConFlow MedTech is a technology firm specializing in high-end cardiovascular medical device research, development, production, and industrial operations. We are dedicated to becoming a top-tier global innovator by continuously advancing cutting-edge technology through independent research, clinical implementation, and high-tech development. Our leadership team boasts over a decade of experience in structural heart disease, featuring professional experts in project research, clinical quality registration, and market sales.
Nestled in the heart of Songjiang Science and Technology City, Shanghai Lingang Group proudly occupies a spacious 2,200-square-meter complex. This facility boasts a pristine environment featuring a 10k Grade clean workshop, well-equipped laboratories, a machining platform, and modern office spaces. Now the company's product line covers heart failure treatment equipment, valve repair and peripheral vascular treatment equipment.
-
July 24,2023Good News | ConFlow MedTech was awarded as "Specialized and Sophisticated SME" in Shanghai City
-
September 18,2023Thank you for being with us as we celebrate the third anniversary of ConFlow MedTech's establishment!
-
August 16,2023Novel Approach for Alleviating Pulmonary Arterial Hypertension: Academician Ge Junbo and Professor Zhou Daxin's Team Utilize FreeFlow® in Clinical Research – Unveiling 1-Year Follow-Up Findings.
Pursue further excellence!
